Literature DB >> 24138022

Childhood hepatocellular carcinoma: a clinicopathological study of 12 cases with special reference to EpCAM.

Yoh Zen1, Roshni Vara, Bernard Portmann, Nedim Hadzic.   

Abstract

AIMS: To elucidate the characteristics of hepatocellular carcinoma (HCC) in children. METHODS AND
RESULTS: A retrospective search of our database identified 12 children with HCC (aged 10 months to 11 years; male/female ratio of 5:7). Their pathological features were compared with those of adult HCCs (n = 20), fibrolamellar HCCs (n = 14), and hepatoblastomas (n = 15). All childhood HCCs developed on a background of cirrhosis resulting from tyrosinaemia type 1 (n = 4), bile salt export transporter deficiency (n = 4), biliary atresia (n = 3), and long-standing total parenteral nutrition (n = 1). HCCs in cases of tyrosinaemia type 1 always had clear cell changes, solid architecture, and only mild nuclear atypia, whereas the morphological features of HCCs in the other conditions were basically similar to those of adult HCCs. On immunostaining, all cases of childhood HCC were positive for epithelial cell adhesion molecule (EpCAM); expression was diffuse (>50% of cancer cells) in 11 cases, and particularly strong in six children, all aged <3 years. In contrast, EpCAM was only focally expressed in three cases of adult HCC (15%). EpCAM was also expressed in most fibrolamellar HCCs and hepatoblastomas, but these two neoplasms differed from childhood HCCs in the expression of CK7, β-catenin, and p53.
CONCLUSIONS: The diffuse expression of EpCAM characterizes childhood HCC, and may indicate immaturity of neoplastic cells.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  bile salt export transporter; biliary atresia; epithelial cell adhesion molecule; hepatoblastoma; hepatocellular carcinoma; progressive intrahepatic cholestasis; stem cell; tyrosinaemia

Mesh:

Substances:

Year:  2013        PMID: 24138022     DOI: 10.1111/his.12312

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  12 in total

1.  H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule.

Authors:  Yongfeng Song; Chune Liu; Xia Liu; Jocelyn Trottier; Michele Beaudoin; Li Zhang; Chad Pope; Guangyong Peng; Olivier Barbier; Xiaobo Zhong; Linheng Li; Li Wang
Journal:  Hepatology       Date:  2017-08-26       Impact factor: 17.425

2.  Paediatric hepatocellular carcinoma in tight junction protein 2 (TJP2) deficiency.

Authors:  Mukul Vij; Naresh P Shanmugam; Mettu Srinivas Reddy; Srinivas Sankaranarayanan; Mohamed Rela
Journal:  Virchows Arch       Date:  2017-07-21       Impact factor: 4.064

Review 3.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

4.  [Hepatocellular carcinomas and their mimics].

Authors:  H-P Fischer; D Goltz
Journal:  Pathologe       Date:  2019-02       Impact factor: 1.011

Review 5.  Rare malignant liver tumors in children.

Authors:  Govind B Chavhan; Iram Siddiqui; Katrina M Ingley; Abha A Gupta
Journal:  Pediatr Radiol       Date:  2019-10-16

6.  Gamma-smooth muscle actin expression is associated with epithelial-mesenchymal transition and stem-like properties in hepatocellular carcinoma.

Authors:  Nassima Benzoubir; Charlotte Mussini; Charlène Lejamtel; Alexandre Dos Santos; Claire Guillaume; Christophe Desterke; Didier Samuel; Christian Bréchot; Marie-Françoise Bourgeade; Catherine Guettier
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

7.  Alagille Syndrome Candidates for Liver Transplantation: Differentiation from End-Stage Biliary Atresia Using Preoperative CT.

Authors:  Sook Min Hwang; Tae Yeon Jeon; So-Young Yoo; Ji Hye Kim; Ben Kang; Yon Ho Choe; Haeyon Cho; Jung Sun Kim
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

8.  Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis.

Authors:  Raffaella Maria Gadaleta; Natasha Scialpi; Claudia Peres; Marica Cariello; Brian Ko; Jian Luo; Emanuele Porru; Aldo Roda; Carlo Sabbà; Antonio Moschetta
Journal:  Sci Rep       Date:  2018-11-21       Impact factor: 4.379

9.  Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.

Authors:  Anastasia Lemekhova; Daniel Hornuss; Georgios Polychronidis; Philipp Mayer; Christian Rupp; Thomas Longerich; Karl-Heinz Weiss; Markus Büchler; Arianeb Mehrabi; Katrin Hoffmann
Journal:  World J Surg Oncol       Date:  2020-05-12       Impact factor: 2.754

Review 10.  Functions of EpCAM in physiological processes and diseases (Review).

Authors:  Li Huang; Yanhong Yang; Fei Yang; Shaomin Liu; Ziqin Zhu; Zili Lei; Jiao Guo
Journal:  Int J Mol Med       Date:  2018-07-11       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.